Results 211 to 220 of about 54,429 (272)

Molecular significance of circRNAs in malignant lymphoproliferative disorders: pathogenesis and novel biomarkers or therapeutic targets. [PDF]

Am J Cancer Res
Long BY, Wang Y, Hao SH, Shi G.
europepmc   +1 more source

Diagnosis of B-cell lymphoproliferative disorder through concomitant management of medication-related osteonecrosis of the jaw: A case report [PDF]

, 2019
Buckley, James G., Champion, Allen F., Diecidue, Robert, Zhou, Ruifeng   +3 more
core   +1 more source

Letermovir prophylaxis for cytomegalovirus is associated with risk of post-transplant lymphoproliferative disorders after haploidentical stem cell transplantation. [PDF]

Haematologica
Pei XY, Huang Q, Luo LJ, Sun HL, Liu J, Sun YQ, Mo XD, Lv M, Liu DH, Ma HY, Wu YW, Xu LP, Wang Y, Zhang XH, Chen L, Huang XJ.   +15 more
europepmc   +1 more source

The Clinical Role of CXCR4-Targeted PET on Lymphoproliferative Disorders: A Systematic Review. [PDF]

J Clin Med
Zamanian M, Albano D, Treglia G, Rizzo A, Abedi I.   +4 more
europepmc   +1 more source

Beyond Chemotherapy: Present and Future Perspectives in the Treatment of Lymphoproliferative Disorders. [PDF]

Biomedicines
Massaro F, Andreozzi F, Abrassart T, Castiaux J, Massa H, Rizzo O, Vercruyssen M.   +6 more
europepmc   +1 more source

Impact of antiviral prophylaxis on EBV viremia and posttransplant lymphoproliferative disorders in solid organ transplant recipients: a systematic review and meta-analysis. [PDF]

Virol J
Moghadamnia M, Delroba K, Heidari S, Rezaie Z, Dashti-Khavidaki S.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Posttransplantation Lymphoproliferative Disorders

American Journal of Clinical Pathology, 1993
Posttransplantation lymphoproliferative disorders (PTLDs) currently affect approximately 2% of all organ allograft recipients. This problem has increased in magnitude in recent years both because of newly available powerful immunosuppressive agents and the steady increase in the number of organs transplanted.
Margaret L Gulley
exaly   +3 more sources

Ocular lymphoproliferative disorders

Current Opinion in Ophthalmology, 2021
Purpose of review Ocular lymphoproliferative disorders are a heterogenous group of pathologic disorders with significant impact on quality of life and, at times, may be life-threatening. Due to the rarity of these disorders, information regarding proper diagnosis, treatment, and prognosis is limited.
Kareem, Moussa, Lesley, Everett
openaire   +2 more sources